David Mitchell: A Tenacious Advocate for Affordable Drugs Passes at 75

Remembering David Mitchell

David Mitchell, who tirelessly championed the rights of patients in the face of soaring medication costs, passed away on January 2, 2026, at 75 years old, after battling multiple myeloma. His story isn't merely that of a public relations executive but more that of an individual transformed by a personal health crisis into a formidable voice against systemic injustices in the pharmaceutical industry.

From Public Relations to Patient Advocacy

Before his life-altering diagnosis in 2010, Mitchell boasted a distinguished career as a founding partner of GMMB, a prominent Washington, D.C. communication firm. However, it was his journey as a cancer patient that he claimed most significantly shaped his identity and mission. He openly described his primary role as a “Cancer Patient, November 2010-Present”—a stark reminder of how personal health battles often translate into broader societal issues.

“It's like extortion,” he lamented while reflecting on the financial strain of his medication. “It's no different than Tony Soprano walking into a store and saying, 'Someone may get hurt if you don't give us the money.'”

Founding Patients for Affordable Drugs

In 2016, Mitchell established Patients for Affordable Drugs, a pivotal organization focused on reducing the financial burden of prescription drugs while advocating for transparency in drug pricing. Mitchell's skills in public relations were invaluable; utilizing his connections and experiences, he was able to galvanize support, inspire countless others in similar circumstances, and effectively communicate the severe effects of soaring drug prices on everyday Americans.

A Legacy of Legislative Accomplishments

Over the years, the work done by Mitchell and his organization helped facilitate crucial legislative changes, including the inclusion of a cap on Medicare drug costs in the Inflation Reduction Act of 2022. Under this law, out-of-pocket expenses for Medicare patients were limited to $3,500 a year, providing financial relief to many struggling with medication costs.

Mitchell's unwavering commitment to advocating for transparent drug pricing often put him at odds with big pharmaceutical companies. “I want to tell the drug companies that it's time for patients to say we're not going to be frightened any longer,” he asserted, speaking against the pressures patients face from pharmaceutical giants.

A Multifaceted Life

Born in Detroit on May 4, 1950, Mitchell's upbringing was modest; his father served as a police officer and his mother worked as a substitute teacher. It was during a grueling summer job on an assembly line that Mitchell decided to pursue higher education. He graduated from Michigan State University, eventually making a mark in labor relations and communications.

This versatility proved essential in his advocacy work. Having previously led campaigns addressing public health issues—like tobacco control and drunk driving—Mitchell brought a wealth of experience to his new role as a patient advocate.

Resilience Amid Adversity

David Mitchell's fight against cancer was not just personal; it became a larger commentary on the failings of the American healthcare system. He often remarked, “we don't have the best health care system in the world; we have the most expensive health care system in the world.” His critical perspective provided the right context for turning personal adversity into a collective call for reform.

“Pharmaceutical companies remind me of an octopus with many, many tentacles,” he expressed, highlighting the complexity and the influence of money in healthcare. “At the end of each tentacle is a wad of cash.”

Personal Life and Legacy

Mitchell's legacy as an advocate and a compassionate human being will resonate long beyond his passing. He is survived by his second wife, Nicole Solomon, and his three children from his first marriage, along with a grandson and siblings. His dedication to advocating for affordable drugs was mirrored by his family, as his wife is also a cancer survivor who worked alongside him at Patients for Affordable Drugs until he stepped back to focus on his health.

A Cautionary Tale

While Mitchell's journey underscores significant strides toward making medication more affordable, it also serves as a reminder of the ongoing challenges many face in securing necessary treatments. His life's work reminds us that markets affect people as much as profits, a belief I share as we explore the intersections of business, healthcare, and human experience.

His story, marked by personal and professional resilience, sheds light on the profound impacts of price discrimination in a sector that touches every individual's life. As we reflect on Mitchell's legacy, may we also embrace the urgency of continuing the fight for transparency and affordability in healthcare.